Related Experiment Video

Updated: Jun 11, 2025

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.9K

Comprehensive proteomics analysis reveals novel Nek2-regulated pathways and therapeutic targets in cancer

Batuhan Mert Kalkan1, Ahmet Tarik Baykal2, Enes Cicek3

  • 1Koç University, Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.

Biochemical and Biophysical Research Communications
|October 5, 2024
PubMed

Insights

Overexpressed Nek2 kinase drives cancer progression. Targeting Nek2, KIF20B, and RRM1 shows promise for new cancer therapies by modulating cell cycle and proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Proteomics

Background:

  • The mitotic kinase Nek2 is frequently overexpressed in various cancers, contributing to cell cycle progression, proliferation, and drug resistance.
  • Targeting Nek2 is a promising strategy for cancer therapy due to its critical roles in cancer cell biology.

Purpose of the Study:

  • To investigate the global proteomic changes associated with Nek2 activity modulation in cancer cells.
  • To identify novel therapeutic targets by understanding Nek2's regulatory network.

Main Methods:

  • Global proteomics analysis using Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS).
  • Bioinformatics analysis to identify differentially regulated molecular pathways.
  • Integration of proteomics data with cancer patient datasets.

Main Results:

  • Identified 358 proteins (out of 1815) significantly regulated by Nek2 activity.
  • Found a strong correlation between Nek2 expression and KIF20B and RRM1 protein levels in cancer patients.
  • Demonstrated that silencing Nek2 significantly reduces KIF20B and RRM1 levels, identifying potential Nek2 phosphorylation sites on these proteins.

Conclusions:

  • KIF20B and RRM1 are identified as potential therapeutic targets, individually or in combination with Nek2 inhibitors.
  • Modulating Nek2 activity impacts key cancer-related proteins, suggesting new avenues for cancer treatment.
  • Further research is warranted to elucidate the precise interactions and clinical significance of Nek2, KIF20B, and RRM1.

More Related Videos

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

359
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.2K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K